Laryngomalacia No Longer An Ambiguity

Laryngomalacia Clinical Trial

Official title:

Laryngomalacia No Longer An Ambiguity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00972764
• Other study ID #: 461956 (BoushahriCMC)
• Status: Completed
• Start date: January 2006
• Est. completion date: September 2008

Study information

• Verified date: January 2020
• Source: Boushahri Clinic Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to expose some of the factors that may be associated or predisposing to development of laryngomalacia.

Description:

Laryngomalacia is the most common congenital malformation of the larynx and it is a self-limited disorder. It is the most common cause of stridor in newborns and infants. It results from an abnormal prolapse of supraglottic structures during inspiration. Despite its widespread prevalence, the etiology of laryngomalacia is unclear. Most infants will squeaky but otherwise well. Although affected patients do not exhibit much in the way of other physical symptoms, the unusual voice is worrisome to their parents.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1500
• Est. completion date: September 2008
• Est. primary completion date: July 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A to 2 Years

Eligibility

Inclusion Criteria:

• Babies delivered with laryngomalacia with = 37 weeks of gestation

• Delivered with birth weights = 2.5 kg

• No history of natal or post-natal complications

• From the same community

Exclusion Criteria:

• Pre-term babies

• History of natal or post-natal complications

Related Conditions & MeSH terms

• Laryngomalacia

Locations

Country	Name	City	State
Kuwait	Boushahri Clinic Medical Center	Kuwait	P.O.Box :698 Salmiya

Sponsors (1)

Lead Sponsor	Collaborator
Boushahri Clinic Medical Center

Country where clinical trial is conducted

Kuwait,